Latest Listicles

Listicle
Evaluating and Optimizing Critical Quality Attributes During Cell Line Development
This listicle presents innovative tools that help optimize CQAs measurement during CLD to avoid late-stage setbacks.

Listicle
Advances in Cancer Biology
Download this listicle to learn about developments in immunotherapy, AI/machine learning and cancer vaccines.

Listicle
Inductively Coupled Plasma-Mass Spectrometry: What Factors Are Driving Its Application Landscape?
Download this listicle to learn more about ICP-MS principles of operation, the components of an ICP mass spectrometer and the applications of ICP-MS.

Listicle
Life Savers – A Brief History of Vaccines
Download this listicle to explore the early days of vaccination, how vaccine production leapt forward, and a new era in vaccines and future challenges.

Listicle
Five Intelligent Ways To Accelerate Cell Line Development
Download this free listicle to learn more about how to use automation to optimize your cell line development workflow.

Listicle
Five Ways To Measure Immunotherapy Potency
This listicle highlights five commonly used cell viability assays and their benefits and limitations in immunotherapy potency testing.

Listicle
Applications of Mass Spectrometry
Download this listicle to explore the many applications of mass spectrometry including pharmaceutical analysis, omics, clinical diagnostics and microbiological testing.

Listicle
Clinical Applications of Cell Therapy
Download this listicle to explore cell therapy applications including oncology, neurodegenerative disease and diabetes.

Listicle
Faster Approaches to Vaccine Design
Download this listicle to learn more about the technologies that have advanced vaccine design including reverse vaccinology 2.0, comparative and subtractive genomics, immunoproteomics and immunopeptidomics, and computational approaches.

Listicle
Recent Advances in Gene Therapy
Download this listicle to explore recent advances in gene therapy such as novel virus-free delivery systems, precision targeting using lipid nanoparticles and safer gene editing systems.
Advertisement